The Center of Reproductive Medicine, formerly the Test Tube Baby Laboratory established in the late 1980s, wherein, the first test tube baby of Mainland China was brought about 16 years ago, and later the nation’s fist test tube via donated oocyte, embryo freezing and Gamete Intrafallopian Transfer (GIFT) etc were successfully cultured, is currently one of the biggest institutes of this kind in the nation since its reconstruction and expanding in 2001. With some 3 years operation, it has reached a capacity of yearly receipt for 50 thousands visits of patients, some of who came with long lasting fertility troubles with remedy seeking all around the nation; and the treatment cycles available for services of test tube baby resorts have reached a level of around 1,000 per year. In April 2004, we successfully passed the inspection by the Ministry of Health, which enable us to be the only passer of this national level inspection among the 6 hospitals in Beijing City who have been inspected by the Ministry of Health.

We are equipped with an construction area of 2500 Square Meters, which includes 14 standard Double Wards, corresponding Clinic facilities and 2 Clinic operating theaters, 3 lamina-flow cleanrooms for procedures (oocyte retrieval, and embryo transfer), oocyte culture and ICSI manipulation respectively, and Molecular Biology Laboratory, Endocrine Laboratory etc. with a total of investment reached to 10 million CNY and a total capability of patient receipts as high as 1,500 people per year.

The center has now employed more than 30 staff (10 with Doctorate and 5 with Master’s degree), of which, there are 4 professors and 5 associate professors.

The items currently available for diagnostic and treatment services include infertility from tubal factors, ovulation problems, female endocrine factors, irregular menses, Polycystic Ovary Syndrome (PCOS), male infertility from oligospermia,azoospermia, or immotile spermatozoa, testicular biopsy, ovulation monitoring, test tube baby (IVT-ET), Intracytoplasma sperm injection (ICSI), Preimplantation Genetic Diagnosis (PGD), Artificial Fertilization (IUI &AID), Fallopian Tube Recanalisation—fluid-based, Pathological biopsy on endometrium, checkup or management withhysteroscope or celioscope, female hormone assays, semen routineand chromosome analyses etc.

We have decades of history for treatment on infertility and gynecological endocrine. In 1958, Professor Zhang Lizhu set up the Department of Obstetrics and Gynecology in the third hospital of Beijing Medical college, and during the course of daily work, she found that cases of amenorrhea, irregular menses and infertility by female endocrine dysfunction were very common in patients from North Beijing, as a result, in company with the development of routine Obstetrical and Gynecological services, investigations and management to dysfunctional diseases of female reproductive endocrine are of similar importance as Gynecology, Obstetrics and Family Planning. And today, diagnosis, management and researches regarding infertility and female reproductive endocrine have been featured in the specialty of Obstetrics and Gynecology in our hospital.

Early in the 1960s, most the postgraduates guided by professor Zhang Lizhu had been focusing their researches on Gynecological Endocrine; and then, in 1970, professor Zhang Lizhu set up the first research institute of female reproductive endocrine of our country with jobs developed for hormone determinations, which enable gradually deeper insights upon the female reproductive endocrine and, as a result, a great quantity of patients offered with top level treatment of that time in the nation. After the ten-year turmoil of cultural revolution, and with the resumption of national education system as well as the great attention by the nation to scientific researches, which had greatly promoted the specialty development of female reproductive endocrine and infertility, a great many of high level postgraduates had been educated and they have already become subject leaders and technical pillars in clinics.

In 1986, Professor Zhang Lizhu initiated the first application research on test tube baby technique in China under very harsh conditions. At that time, when oocyte retrieval must resort to abdominal incisions, she chose a strategy that allowed a concurrent oocyte retrieval to occur via ovarian puncture on patients who were undergoing surgeries to remove pelvic lesion that provided a remedy to their r